DANIEL KRUGER: Open Payments
NPI 1619684842 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 34 payments from 16 companies in 2025. Trend: 2023 $731 · 2024 $670 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $277 |
| PFIZER INC. | 5 | $103 |
| Amgen Inc. | 2 | $50 |
| Novo Nordisk Inc | 2 | $43 |
| IBSA Pharma Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Boston Scientific Corporation | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
Products named: UBRELVY, VRAYLAR, QULIPTA, KRYSTEXXA, NURTEC ODT, Tirosint, AIRSUPRA, WATCHMAN Access System.
Industry payments across CO — which companies pay providers there.
